Pharma & Healthcare

Headache Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Headache medicine can provide headache relief for your pain. The best medicine for headaches depends on the headache frequency and severity. There are several types of headache medicines available, both over-the-counter (OTC) and prescription, that can help alleviate headache symptoms. The choice of medication depends on the type and severity of the headache, as well as other individual factors.
The global market for Headache Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
One of the primary market drivers for headache medicine is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person's quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Headache Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Headache Medicine by region & country, by Type, and by Application.
The Headache Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Headache Medicine.
Market Segmentation
By Company
GSK
Teva
Pfizer
Novartis
Bayer
Allergan
Grunenthal
Johnson & Johnson
Eli Lilly
Segment by Type:
NSAIDs
Triptans
Others
Segment by Application
Drug Stores
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Headache Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Headache Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Headache Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Headache Medicine Product Introduction
1.2 Global Headache Medicine Market Size Forecast
1.3 Headache Medicine Market Trends & Drivers
1.3.1 Headache Medicine Industry Trends
1.3.2 Headache Medicine Market Drivers & Opportunity
1.3.3 Headache Medicine Market Challenges
1.3.4 Headache Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Headache Medicine Players Revenue Ranking (2023)
2.2 Global Headache Medicine Revenue by Company (2019-2024)
2.3 Key Companies Headache Medicine Manufacturing Base Distribution and Headquarters
2.4 Key Companies Headache Medicine Product Offered
2.5 Key Companies Time to Begin Mass Production of Headache Medicine
2.6 Headache Medicine Market Competitive Analysis
2.6.1 Headache Medicine Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Headache Medicine Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Headache Medicine as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 NSAIDs
3.1.2 Triptans
3.1.3 Others
3.2 Global Headache Medicine Sales Value by Type
3.2.1 Global Headache Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Headache Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Headache Medicine Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Stores
4.1.2 Hospital
4.2 Global Headache Medicine Sales Value by Application
4.2.1 Global Headache Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Headache Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Headache Medicine Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Headache Medicine Sales Value by Region
5.1.1 Global Headache Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Headache Medicine Sales Value by Region (2019-2024)
5.1.3 Global Headache Medicine Sales Value by Region (2025-2030)
5.1.4 Global Headache Medicine Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Headache Medicine Sales Value, 2019-2030
5.2.2 North America Headache Medicine Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Headache Medicine Sales Value, 2019-2030
5.3.2 Europe Headache Medicine Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Headache Medicine Sales Value, 2019-2030
5.4.2 Asia Pacific Headache Medicine Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Headache Medicine Sales Value, 2019-2030
5.5.2 South America Headache Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Headache Medicine Sales Value, 2019-2030
5.6.2 Middle East & Africa Headache Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Headache Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Headache Medicine Sales Value
6.3 United States
6.3.1 United States Headache Medicine Sales Value, 2019-2030
6.3.2 United States Headache Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Headache Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Headache Medicine Sales Value, 2019-2030
6.4.2 Europe Headache Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Headache Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Headache Medicine Sales Value, 2019-2030
6.5.2 China Headache Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Headache Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Headache Medicine Sales Value, 2019-2030
6.6.2 Japan Headache Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Headache Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Headache Medicine Sales Value, 2019-2030
6.7.2 South Korea Headache Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Headache Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Headache Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Headache Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Headache Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Headache Medicine Sales Value, 2019-2030
6.9.2 India Headache Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Headache Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GSK
7.1.1 GSK Profile
7.1.2 GSK Main Business
7.1.3 GSK Headache Medicine Products, Services and Solutions
7.1.4 GSK Headache Medicine Revenue (US$ Million) & (2019-2024)
7.1.5 GSK Recent Developments
7.2 Teva
7.2.1 Teva Profile
7.2.2 Teva Main Business
7.2.3 Teva Headache Medicine Products, Services and Solutions
7.2.4 Teva Headache Medicine Revenue (US$ Million) & (2019-2024)
7.2.5 Teva Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Headache Medicine Products, Services and Solutions
7.3.4 Pfizer Headache Medicine Revenue (US$ Million) & (2019-2024)
7.3.5 Novartis Recent Developments
7.4 Novartis
7.4.1 Novartis Profile
7.4.2 Novartis Main Business
7.4.3 Novartis Headache Medicine Products, Services and Solutions
7.4.4 Novartis Headache Medicine Revenue (US$ Million) & (2019-2024)
7.4.5 Novartis Recent Developments
7.5 Bayer
7.5.1 Bayer Profile
7.5.2 Bayer Main Business
7.5.3 Bayer Headache Medicine Products, Services and Solutions
7.5.4 Bayer Headache Medicine Revenue (US$ Million) & (2019-2024)
7.5.5 Bayer Recent Developments
7.6 Allergan
7.6.1 Allergan Profile
7.6.2 Allergan Main Business
7.6.3 Allergan Headache Medicine Products, Services and Solutions
7.6.4 Allergan Headache Medicine Revenue (US$ Million) & (2019-2024)
7.6.5 Allergan Recent Developments
7.7 Grunenthal
7.7.1 Grunenthal Profile
7.7.2 Grunenthal Main Business
7.7.3 Grunenthal Headache Medicine Products, Services and Solutions
7.7.4 Grunenthal Headache Medicine Revenue (US$ Million) & (2019-2024)
7.7.5 Grunenthal Recent Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Profile
7.8.2 Johnson & Johnson Main Business
7.8.3 Johnson & Johnson Headache Medicine Products, Services and Solutions
7.8.4 Johnson & Johnson Headache Medicine Revenue (US$ Million) & (2019-2024)
7.8.5 Johnson & Johnson Recent Developments
7.9 Eli Lilly
7.9.1 Eli Lilly Profile
7.9.2 Eli Lilly Main Business
7.9.3 Eli Lilly Headache Medicine Products, Services and Solutions
7.9.4 Eli Lilly Headache Medicine Revenue (US$ Million) & (2019-2024)
7.9.5 Eli Lilly Recent Developments
8 Industry Chain Analysis
8.1 Headache Medicine Industrial Chain
8.2 Headache Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Headache Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Headache Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Headache Medicine Market Trends
Table 2. Headache Medicine Market Drivers & Opportunity
Table 3. Headache Medicine Market Challenges
Table 4. Headache Medicine Market Restraints
Table 5. Global Headache Medicine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Headache Medicine Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Headache Medicine Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Headache Medicine Product Type
Table 9. Key Companies Time to Begin Mass Production of Headache Medicine
Table 10. Global Headache Medicine Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Headache Medicine as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Headache Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Headache Medicine Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Headache Medicine Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Headache Medicine Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Headache Medicine Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Headache Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Headache Medicine Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Headache Medicine Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Headache Medicine Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Headache Medicine Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Headache Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Headache Medicine Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Headache Medicine Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Headache Medicine Sales Value by Region (2019-2024) & (%)
Table 27. Global Headache Medicine Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Headache Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Headache Medicine Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Headache Medicine Sales Value, (2025-2030) & (US$ Million)
Table 31. GSK Basic Information List
Table 32. GSK Description and Business Overview
Table 33. GSK Headache Medicine Products, Services and Solutions
Table 34. Revenue (US$ Million) in Headache Medicine Business of GSK (2019-2024)
Table 35. GSK Recent Developments
Table 36. Teva Basic Information List
Table 37. Teva Description and Business Overview
Table 38. Teva Headache Medicine Products, Services and Solutions
Table 39. Revenue (US$ Million) in Headache Medicine Business of Teva (2019-2024)
Table 40. Teva Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Headache Medicine Products, Services and Solutions
Table 44. Revenue (US$ Million) in Headache Medicine Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Headache Medicine Products, Services and Solutions
Table 49. Revenue (US$ Million) in Headache Medicine Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. Bayer Basic Information List
Table 52. Bayer Description and Business Overview
Table 53. Bayer Headache Medicine Products, Services and Solutions
Table 54. Revenue (US$ Million) in Headache Medicine Business of Bayer (2019-2024)
Table 55. Bayer Recent Developments
Table 56. Allergan Basic Information List
Table 57. Allergan Description and Business Overview
Table 58. Allergan Headache Medicine Products, Services and Solutions
Table 59. Revenue (US$ Million) in Headache Medicine Business of Allergan (2019-2024)
Table 60. Allergan Recent Developments
Table 61. Grunenthal Basic Information List
Table 62. Grunenthal Description and Business Overview
Table 63. Grunenthal Headache Medicine Products, Services and Solutions
Table 64. Revenue (US$ Million) in Headache Medicine Business of Grunenthal (2019-2024)
Table 65. Grunenthal Recent Developments
Table 66. Johnson & Johnson Basic Information List
Table 67. Johnson & Johnson Description and Business Overview
Table 68. Johnson & Johnson Headache Medicine Products, Services and Solutions
Table 69. Revenue (US$ Million) in Headache Medicine Business of Johnson & Johnson (2019-2024)
Table 70. Johnson & Johnson Recent Developments
Table 71. Eli Lilly Basic Information List
Table 72. Eli Lilly Description and Business Overview
Table 73. Eli Lilly Headache Medicine Products, Services and Solutions
Table 74. Revenue (US$ Million) in Headache Medicine Business of Eli Lilly (2019-2024)
Table 75. Eli Lilly Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Headache Medicine Downstream Customers
Table 79. Headache Medicine Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Headache Medicine Product Picture
Figure 2. Global Headache Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Headache Medicine Sales Value (2019-2030) & (US$ Million)
Figure 4. Headache Medicine Report Years Considered
Figure 5. Global Headache Medicine Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Headache Medicine Revenue in 2023
Figure 7. Headache Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. NSAIDs Picture
Figure 9. Triptans Picture
Figure 10. Others Picture
Figure 11. Global Headache Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Headache Medicine Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Drug Stores
Figure 14. Product Picture of Hospital
Figure 15. Global Headache Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Headache Medicine Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Headache Medicine Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Headache Medicine Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Headache Medicine Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Headache Medicine Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Headache Medicine Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Headache Medicine Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Headache Medicine Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Headache Medicine Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Headache Medicine Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Headache Medicine Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Headache Medicine Sales Value (%), (2019-2030)
Figure 28. United States Headache Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Headache Medicine Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Headache Medicine Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Headache Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Headache Medicine Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Headache Medicine Sales Value by Application (%), 2023 VS 2030
Figure 34. China Headache Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Headache Medicine Sales Value by Type (%), 2023 VS 2030
Figure 36. China Headache Medicine Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Headache Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Headache Medicine Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Headache Medicine Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Headache Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Headache Medicine Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Headache Medicine Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Headache Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Headache Medicine Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Headache Medicine Sales Value by Application (%), 2023 VS 2030
Figure 46. India Headache Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Headache Medicine Sales Value by Type (%), 2023 VS 2030
Figure 48. India Headache Medicine Sales Value by Application (%), 2023 VS 2030
Figure 49. Headache Medicine Industrial Chain
Figure 50. Headache Medicine Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies